REQUEST A DEMO
Total
USD $0.00
Search more companies

Biovet AD (Bulgaria)

Main Activities: Other Animal Food Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Biovet AD Profile Updated: September 30, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2019 Available in: English Download a sample report

Biovet, established in 1961, is a leading veterinary drug manufacturer in Bulgaria. The company, which is headquartered in Peshtera, 120 km southeast of the capital Sofia, has 4 production plants - three in Bulgaria, located in the towns of Peshtera, Blagoevgrad and Razgrad and one in Macedonia, Stip. The product portfolio of the firm features more than 80 items for animal health, human health and enzymes, which are sold in over 80 countries across the world.
A total of 25% of Biovet's equity capital was sold against privatisation vouchers in 1997 and 15% was earmarked for sale to employees. In April 2000, Bulgaria sold 54% in Biovet to the Bulgarian Pharmaceutical Company (BPC) for USD 10.6 million in cash and the local company later raised its stake to 81% through stock exchange purchases and capital hikes.

Headquarters
39 Petar Rakov Str.
Peshtera; Pazardzhik; Postal Code: 4550

Contact Details: Purchase the Biovet AD report to view the information.

Website: http://www.biovet.com

Basic Information
Total Employees:
Purchase the Biovet AD report to view the information.
Outstanding Shares:
Purchase the Biovet AD report to view the information.
Registered Capital:
Purchase the Biovet AD report to view the information.
Financial Auditors:
Purchase the Biovet AD report to view the information.
Ratings:
Purchase the Biovet AD report to view the information.
Incorporation Date:
June 30, 1989
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
95.54%
Subsidiaries
ABIO EOOD
100%
Stock energy
100%
BioTehIno OOD
50.8%
Company Performance
Financial values in the chart are available after Biovet AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
11.92%
Total operating revenue
13.37%
Operating profit (EBIT)
4.85%
EBITDA
6.07%
Net Profit (Loss) for the Period
4.41%
Total assets
8.19%
Total equity
16.07%
Operating Profit Margin (ROS)
-0.73%
Net Profit Margin
-0.69%
Return on Equity (ROE)
-1.59%
Debt to Equity Ratio
11.99%
Quick Ratio
-0.18%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?